BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22288421)

  • 1. T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival.
    Clark MC; Baum LG
    Ann N Y Acad Sci; 2012 Apr; 1253():58-67. PubMed ID: 22288421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death.
    Hernandez JD; Nguyen JT; He J; Wang W; Ardman B; Green JM; Fukuda M; Baum LG
    J Immunol; 2006 Oct; 177(8):5328-36. PubMed ID: 17015718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death.
    Earl LA; Bi S; Baum LG
    J Biol Chem; 2010 Jan; 285(4):2232-44. PubMed ID: 19920154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death.
    Lantéri M; Giordanengo V; Hiraoka N; Fuzibet JG; Auberger P; Fukuda M; Baum LG; Lefebvre JC
    Glycobiology; 2003 Dec; 13(12):909-18. PubMed ID: 12925577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytic CD43 and CD45 bear sulfate residues potentially implicated in cell to cell interactions.
    Giordanengo V; Limouse M; Peyron JF; Lefebvre JC
    Eur J Immunol; 1995 Jan; 25(1):274-8. PubMed ID: 7843243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How do protein-glycan interactions regulate T-cell physiology?].
    Toscano MA; Ilarregui JM; Bianco GA; Rubinstein N; Rabinovich GA
    Medicina (B Aires); 2006; 66(4):357-62. PubMed ID: 16977975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD45 glycosylation controls T-cell life and death.
    Earl LA; Baum LG
    Immunol Cell Biol; 2008 Oct; 86(7):608-15. PubMed ID: 18607388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infection.
    Mazurov D; Ilinskaya A; Heidecker G; Filatov A
    J Virol; 2012 Mar; 86(5):2447-58. PubMed ID: 22171268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans.
    Nguyen JT; Evans DP; Galvan M; Pace KE; Leitenberg D; Bui TN; Baum LG
    J Immunol; 2001 Nov; 167(10):5697-707. PubMed ID: 11698442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.
    Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF
    J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell activation results in microheterogeneous changes in glycosylation of CD45.
    Hernandez JD; Klein J; Van Dyken SJ; Marth JD; Baum LG
    Int Immunol; 2007 Jul; 19(7):847-56. PubMed ID: 17606981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells.
    Brown TJ; Shuford WW; Wang WC; Nadler SG; Bailey TS; Marquardt H; Mittler RS
    J Biol Chem; 1996 Nov; 271(44):27686-95. PubMed ID: 8910360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells.
    Baum LG; Pang M; Perillo NL; Wu T; Delegeane A; Uittenbogaart CH; Fukuda M; Seilhamer JJ
    J Exp Med; 1995 Mar; 181(3):877-87. PubMed ID: 7869048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimensions and Interactions of Large T-Cell Surface Proteins.
    Junghans V; Santos AM; Lui Y; Davis SJ; Jönsson P
    Front Immunol; 2018; 9():2215. PubMed ID: 30319654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD43-independent augmentation of mouse T-cell function by glycoprotein cleaving enzymes.
    Berger SB; Sadighi Akha AA; Miller RA; Garcia GG
    Immunology; 2006 Oct; 119(2):178-86. PubMed ID: 16805789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site.
    Sperling AI; Sedy JR; Manjunath N; Kupfer A; Ardman B; Burkhardt JK
    J Immunol; 1998 Dec; 161(12):6459-62. PubMed ID: 9862667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of CD43 and other lymphocyte O-glycoproteins by core 2 N-acetylglucosaminyltransferase.
    Barran P; Fellinger W; Warren CE; Dennis JW; Ziltener HJ
    Glycobiology; 1997 Feb; 7(1):129-36. PubMed ID: 9061371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of a new secreted sulfated mucin-like protein with a C-type lectin domain that is expressed in lymphoblastic cells.
    Bannwarth S; Giordanengo V; Lesimple J; Lefebvre JC
    J Biol Chem; 1998 Jan; 273(4):1911-6. PubMed ID: 9442024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage.
    Pericolini E; Gabrielli E; Bistoni G; Cenci E; Perito S; Chow SK; Riuzzi F; Donato R; Casadevall A; Vecchiarelli A
    PLoS One; 2010 Sep; 5(9):e12720. PubMed ID: 20856869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of the cell-surface O-sialoglycoproteins CD34, CD43, CD44, and CD45 by a novel glycoprotease from Pasteurella haemolytica.
    Sutherland DR; Abdullah KM; Cyopick P; Mellors A
    J Immunol; 1992 Mar; 148(5):1458-64. PubMed ID: 1371528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.